WellBrain- mobile addiction prevention & pain program

Easily deployable AI/ML/digital phenotyping driven mobile digital addiction prevention and chronic pain management platform

1) The opiate epidemic is a catastrophe. Many patients with pain started on opiates cycle into addiction. Chronic pain affects 1.5 billion worldwide. Opiates aren't working. The world wants a different solution. That solution is WellBrain. 

2) Founded & led by 3 Harvard, Stanford, & Mayo clinic trained pain physicians along with a digital  health gamification expert, WellBrain is a B2B2C digital health addiction prevention and chronic pain management platform that frontline providers can easily deploy to their patients using a smartphone app providing patients with a personalized assessment of mental health including risk of opiate abuse and then using artificial intelligence/machine learning and digital phenotyping to customize an array of evidenced based non opiate modalities to best manage pain and fight the opiate epidemic.  We are live, post-MVP, and have demonstrated a reduction in ER visits, reduction in opioid Rxs, & improvement in pain

3) Our solution is a gamechanger as it will save lives from the opiate epidemic, help millions with chronic pain, and help prevent the opiate catastrophe from happening again.

Our integration of smart phone based digital phenotyping with AI and ML is a unique application of an existing technology in mobile health

We recently acquired a company called Mevoked that is focused on helping identify and manage patients with postpartum depression through smart phone based digital phenoytping. We plan on integrating this technology so that can we personalize care at the right time away from the medical office 

Our cloud-based platform for the 1.75 billion people with smartphones allows for a rapidly scalable solution enabling the ability to deliver the right management at the right time outside of the physician's office through digital phenotyping and deliver an even more personalized and optimized solution over time using ML/AI

WellBrain has plans to roll out to 200 provider offices in 2018. With more data, we will be able to optimize the program deliver better care for each patient and have figured out how to best deploy our platform to providers and patients to optimize adherence

Expand to 200 provider offices in the United States

Execute trials with Kaiser for managing pain around knee surgery, MD Anderson for palliative care, and Columbia University for thoracic postsurgical pain

Deploy globally through MIT Solve to providers and patients abroad in need for free consistent with WellBrain's mission-driven approach in helping those in need

Integrate digital phenotyping into the product, add telecoaching, as well as optimize AI/ML engine to build a better product

Save 100 lives from opiate addiction

With a first mover advantage with acceptance into the marketplace, an innovative and patent protected product, and viral effects from scale, we can scale to become the largest digital addiction prevention & chronic pain program globally helping millions of lives of the 1.5 billion worldwide who experience chronic pain. Our platform can then likely scale to other chronic medical conditions that are underaddressed such as postpartum depression and a wide plethora of other diseases

We are expanding our sales team to focus on the United States providers and hospitals. We plan on working with NGO's and medical mission groups such as Doctors without Borders to deploy WellBrain for free abroad.

As long as a patient has a smartphone, they will be able to access our addiction prevention and chronic pain program.

10000 patients

20% reduction in ER visits

20% reduction in opiate use

25% improvement in pain control

The population of 1.5 billion patients worldwide with chronic pain

Target initial population- United States. We are growing rapidly and anticipate 100,000 patients using WellBrain in 12 month and 3 million in 3 years.

We expect to see a reduction in opiate overdoses, opiate use, emergency room visits for pain (most common reason for coming to the ER), & improvement in pain control 

Extraordinary domain expertise- Our founding team of physicians trained at Harvard, Stanford, and the Mayo Clinic with over 50 years of clinical expertise as clinical leaders in the field. Our CEO founded 3 gaming companies prior having raised over $50M previously. We are mission driven company taking on one of the 21st century's biggest challenges and have been successful in attracting the best and brightest who are motivated to do good for the world

1. Physician-Payor Model

Per-transaction payor reimbursement shared with providers. Generating revenue since Mar’16.  Shifting to flat monthly SAAS fee model with 10 new providers coming on board in June

2. Patient Direct

Direct to Patient subscription platform use @Home module

3. Medical Device and Pharmas 3rd parties want access to a more patient-centric solution and showcasing non-opiate modalities that might be beneficial for patients through our platform has garnered strong interest of medical device/pharma companies. We already have 2 partnerships with big device companies and want to promote evidence based non-opiate approaches that can help in addiction prevention and chronic pain

4. Hospitals

Three pilots in process with Kaiser, John Muir and Columbia.  

5. Insurance Companies

Directly integration of WellBrain into their systems post studies of reduced opioid and ER visits

I was honored to be invited to SOLVE to help facilitate at the Brain Leadership in 2018. I was impressed by those attending really driven to change the world for the better. I only see strong growth and value from SOLVE as they bring in the world's best changemakers. SOLVE will help us connect to those organizations that can help spread the benefits of WellBrain around the globe

Lack of awareness on what we are doing. SOLVE will elevate our game in the mission-driven world much as the Shark Tank does for consumer companies